Physician

Jesus Enrique Hidalgo, M.D.

According to 2025 Medicare claims, Jesus Hidalgo, M.D. (NPI: 1255656476) practices general surgery in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is CARENOMICS, PA (NPI: 1154897247) and primary practice location at 79410-1317.

Hidalgo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 310 traditional Medicare patients, billed 30,785 HCPCS/CPT codes, and received $3,061,428 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,077 prescription claims across 415 beneficiaries totaling $34,650 in drug costs, led by Gentamicin Sulfate (Gentamicin Sulfate). DME data shows 428 claims. Open Payments data shows 1 records totaling $137. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,090 to $3,061,428. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $39,265 and ending at $34,650. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $39,603 and ending at $46,139.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	13	18	$1,090
2016	242	4,202	$208,219
2017	319	7,286	$342,199
2018	370	6,112	$230,798
2019	281	18,115	$790,499
2020	261	46,763	$3,455,967
2021	273	36,430	$5,009,806
2022	284	37,206	$2,980,295
2023	283	31,650	$2,830,100
2024	310	30,785	$3,061,428

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	166	411	$39,265
2017	256	729	$64,630
2018	291	922	$157,782
2019	329	1,222	$88,030
2020	339	1,166	$45,826
2021	385	1,382	$53,263
2022	418	1,419	$157,409
2023	403	1,160	$54,850
2024	415	1,077	$34,650

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	113	247	$29,147
2017	332	477	$68,324
2018	307	440	$56,386
2019	214	372	$55,673
2020	216	409	$59,210
2021	278	506	$65,511
2022	205	336	$30,575
2023	202	366	$47,968
2024	244	428	$26,617

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	154	154	$116
11042	Removal of skin and tissue, 20.0 sq cm or less	260	2,514	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	189	385	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	91	144	$67
11045	Removal of skin and tissue, each additional 20.0 sq cm or less	61	505	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gentamicin Sulfate	Gentamicin Sulfate	451	12,077	$17,558
Metronidazole	Metronidazole	32	811	$2,008
Clobetasol Propionate	Clobetasol Propionate	56	1,194	$1,553
Doxycycline Hyclate	Doxycycline Hyclate	94	1,607	$1,283
Pentoxifylline	Pentoxifylline	17	780	$1,243

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	41	66	$8,375
A6209	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	N	37	55	$4,958
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	N	14	22	$4,206
A6210	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing	N	N/R	15	$3,667
A4452	Tape, waterproof, per 18 square inches	N	59	82	$1,404

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$137	AngioDynamics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jesus Enrique Hidalgo, M.D.?

Tedicare shows public-source Medicare data for Jesus Enrique Hidalgo, M.D. (NPI 1255656476), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jesus Enrique Hidalgo, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jesus Enrique Hidalgo, M.D.?

Jesus Enrique Hidalgo, M.D. is linked to CARENOMICS, PA (billing NPI 1154897247) in the available physician profile data.

Does Jesus Enrique Hidalgo, M.D. have Open Payments data?

Jesus Enrique Hidalgo, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.